Vanguard Group Inc Harmony Biosciences Holdings, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,097,176 shares of HRMY stock, worth $173 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,097,176
Previous 5,110,780 0.27%
Holding current value
$173 Million
Previous $162 Million 13.02%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$26.76 - $38.05 $364,043 - $517,632
-13,604 Reduced 0.27%
5,097,176 $140 Million
Q2 2025

Aug 11, 2025
BUY
$27.94 - $35.91 $11.5 Million - $14.8 Million
411,427 Added 8.75%
5,110,780 $162 Million
Q1 2025

May 09, 2025
SELL
$32.18 - $40.46 $1.1 Million - $1.39 Million
-34,256 Reduced 0.72%
4,699,353 $156 Million
Q4 2024

Feb 11, 2025
BUY
$31.86 - $41.49 $40.2 Million - $52.4 Million
1,262,362 Added 36.37%
4,733,609 $163 Million
Q3 2024

Nov 13, 2024
SELL
$30.0 - $39.95 $1.44 Million - $1.92 Million
-48,140 Reduced 1.37%
3,471,247 $139 Million
Q2 2024

Aug 13, 2024
SELL
$28.81 - $33.01 $3.14 Million - $3.59 Million
-108,838 Reduced 3.0%
3,519,387 $106 Million
Q1 2024

May 10, 2024
SELL
$29.93 - $35.06 $1.39 Million - $1.63 Million
-46,539 Reduced 1.27%
3,628,225 $122 Million
Q4 2023

Feb 14, 2024
SELL
$19.2 - $33.78 $180,249 - $317,126
-9,388 Reduced 0.25%
3,674,764 $119 Million
Q3 2023

Nov 14, 2023
BUY
$31.89 - $39.03 $2.82 Million - $3.45 Million
88,295 Added 2.46%
3,684,152 $121 Million
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $1.85 Million - $2.27 Million
60,572 Added 1.71%
3,595,857 $127 Million
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $8.64 Million - $15.1 Million
280,644 Added 8.62%
3,535,285 $115 Million
Q4 2022

Feb 10, 2023
BUY
$45.4 - $60.91 $11.4 Million - $15.3 Million
251,185 Added 8.36%
3,254,641 $179 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $1.64 Million - $2.16 Million
38,958 Added 1.31%
3,003,456 $133 Million
Q2 2022

Aug 12, 2022
BUY
$33.54 - $52.15 $8.79 Million - $13.7 Million
261,985 Added 9.69%
2,964,498 $145 Million
Q1 2022

May 13, 2022
BUY
$33.14 - $51.13 $1.44 Million - $2.22 Million
43,428 Added 1.63%
2,702,513 $131 Million
Q4 2021

Feb 14, 2022
SELL
$34.09 - $43.91 $15 Million - $19.4 Million
-440,856 Reduced 14.22%
2,659,085 $113 Million
Q3 2021

Nov 12, 2021
BUY
$25.68 - $38.61 $49.8 Million - $74.8 Million
1,938,066 Added 166.81%
3,099,941 $119 Million
Q2 2021

Aug 13, 2021
BUY
$25.96 - $33.44 $30.2 Million - $38.9 Million
1,161,875 New
1,161,875 $32.8 Million

Others Institutions Holding HRMY

# of Institutions
318
Shares Held
42.8M
Call Options Held
1.05M
Put Options Held
310K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email